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ABSTRACT 
 
Tuberculosis (TB) and tobacco use are two major alarming global health issues posing immense threats to 
human populations. Mycobacterium tuberculosis (MTB) by activation of macrophages could induce the 
sequences of cells activation and releases of inflammatory cytokines such as CXCL-8, Il-12 and TNF-α which in 
turn induces the immune system network. However no information is available on other activity of cells by MTB 
and smoking. In the current study we aimed to investigate the serum levels TNF-, CXCL-8 and phagocytosis 
capacity in tuberculosis patients with and without smoking. 
103 subjects entered the study including 61 new diagnosed pulmonary TB patients (23 smokers and 38 
nonsmokers) and 42 control healthy subjects. The phagocytosis of fluorescein isothiocyanate dextran (FITC-
dextran) in blood monocytes/macrophages through flowcytometry was assessed. Serum levels of TNF- and 
CXCL-8 were analyzed by ELISA methods.  
A lower percentage of cells from TB patients who smoked [50.29% (43.4-57.2), p<0.01] took up FITC-
dextran after 2h compared to non-smoking TB subjects [71.62% (69.2-74.1)] and healthy cases [97.45% (95.9-
99.1). Phagocytic capacity was inversely correlated with cigarette smoking as measured by pack years (r=-0.73, 
p<0.001). The serum levels of TNF- and CXCL-8 were significantly higher in the TB patients who smoked 
compared to the TB non-smoker group (p<0.001, p<0.01 respectively).  
Blood monocytes/macrophages from TB patients have reduced phagocytic capacity which is further reduced 
in TB patients who smoke. Smoking enhanced serum levels of TNF- and CXCL-8 suggesting a greater 
imbalance between the proinflammatory and anti-inflammatory factors in these patients.  
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INTRODUCTION 
 
The association between tobacco smoke and 
tuberculosis (TB) has been considered recently. 
Tuberculosis (TB) and tobacco use are two major 
alarming global health issues posing immense threats to 
human populations.
1
 Most of the morbidity and 
mortality from tuberculosis occurs in developing 
countries, which incidentally, smoking is still the most 
common problem.
2
 
Mycobacterium Tuberculosis (Mtb) is an 
intracellular pathogen of human mononuclear 
phagocytes. As with many other bacteria, the 
interaction of Mtb with innate and adaptive immune 
mechanisms specifies the infection prognosis.
3
 
Mtb has developed mechanisms to evade from 
immune surveillance at many steps in the host 
response.
4,5
 Mtb may impair the recognition of 
phagocytic activity of macrophages and neutrophils in 
different ways.  
It has been proposed that the correlation of TB and 
smoking could be due to the inhibitory effect of 
nicotine on production of TNF-α by the lung 
macrophages which make the patients susceptible to 
the development of progressive latent infection to the 
active form.
6
 
Smoking impairs the phagocytic function of 
alveolar macrophages.
7
 Both smoking and tuberculosis 
induce apoptosis of macrophages.
8,9
 Cigarette smoke 
activates macrophages to produce a local inflammatory 
response,
10
 but nicotine as important component of 
smoke suppresses the antigen presentation function to 
develop a specific immune response.
11
 Chronic 
exposure to cigarette smoke reduces expression of 
surface proteins related to antigen presentation by 
macrophages.
12,13
 
Macrophage/monocyte is important in the function 
of the immune system and macrophage-derived 
cytokines play role in the immune system.
14
 Mtb 
infection recruit the Inﬂammatory cells in the lungs and 
these inﬁltrating cells constitute into a construction 
named granuloma that controls and contains infection.
15
 
The formation process of granulomas and its 
influencing factors are unknown but it seems that the 
TNF- plays an important role in this process.15 TNF-α 
produced by the macrophages which activated by 
endotoxins.
16
 Treatments that modulate TNF-α 
production are reported to be associated with higher 
susceptibility of patients to TB disease and may 
reactivate the latent from of diseases.
17,18
 
Interleukin-8 (CXCL8) is found to be chemo 
attraction and regulation of white blood cell 
production
15
 which can affect the pathogenesis of 
intensive infectious diseases such as TB by suppressing 
the normal immune response to Mtb that can lead to 
granuloma formation.
19
 Although monocytes and 
macrophages infected with Mtb are the main sources of 
CXCL8 production,
20
 but it can also be produced by 
neutrophils and respiratory epithelial cells as well.
21,22
 
It is probable that CXCL8 is responsible for 
aggregation of neutrophils at infection sites in TB 
patients, however, it has not been proven yet.
23
 
Cigarette smoking is a major risk factor for acute 
and chronic respiratory tract infections and can be 
expected to affect human health.
24 
Modulation of 
macrophage function by tobacco and smoking has been 
extensively reviewed.
25
 Aqueous phases
26
 of cigarette 
smoke with more than 5000 compounds exist in blood 
stream,
27-29
 and those particles could affect on 
inflammatory cells.
30
 These compound enter to the cells 
and activate / suppress the activity of macrophage.
7,10
  
In fact MTB by activation of macrophages via 
dectin receptor activate the sequences of cells 
activation and release of inflammatory cytokines such 
as CXCL-8, Il-12 and TNF-α release which in turn 
induces the immune system network.
31-33
 However we 
don’t know how phagocytosis suppression happened in 
TB and cigarette smoke patients. Only we could 
speculate that smoking suppress the capacity of cells 
which induces phagocytosis. 
Our study goal was to define smoking effects on the 
phagocyte capacity of blood monocytes/macrophages 
and levels of inflammatory mediators such as TNF- 
and CXCL-8 in TB patients. 
 
MATERIALS AND METHODS 
 
103 subjects including 61 newly diagnosed 
pulmonary TB patients (23 smokers and 38 
nonsmokers) and 42 controls healthy cases were 
studied. Smoker patients had history of 26.4±16.3 
pack-year smoking. Control and non-smoker TB 
patients were selected from people with no history of 
passive smoking.  
Samples were selected from both genders, aged 18 
years and older. Inclusion criteria were as follows: 
being diagnosed with active pulmonary TB based on 
the classification extracted from the WHO treatment 
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guidelines
34
 and being classified as a category I patients 
(new TB cases). Subjects were excluded if they had 
only extra pulmonary TB (involving CNS, pericardium, 
adrenal gland etc.), had multi-drug resistant TB at 
diagnosis, had HIV/AIDS, were an active IV drug 
abuser, were classified as category II (relapse, 
treatment failure, and treatment after default) or 
category III (chronic TB), fulfilled the eligibility 
criteria but were not willing to participate in the study 
or were unable to comprehend the contents of the 
informed consent form. 
 
Chemicals and Reagents 
Fluorescein isothiocyanate (FITC)-dextran (average 
molecular mass, 40 kDa) was purchased from Sigma-
Aldrich (St. Louis, Mo., USA). CXCL-8 (R&D 
system,USA),TNF-α (Invitrogen ,USA) ELISA kits, 
Ficoll- hypaque (Pharmacia, Uppsala, Sweden), FCS 
(fetal Calf serum, Greiner Bio-One, Germany). 
 
Isolation of Monocytes/Macrophages from 
Peripheral Blood 
Venous blood was drawn from cases in all groups; 
healthy volunteers and TB patients and harvested  
in coagulated tubes containing the 1/10 vol of 3.8% 
sodium citrate. Peripheral blood mononuclear cells 
(PBMC) were prepared by Ficoll-hypaque density 
gradient isolation by centrifugation of freshly drawn 
blood. PBMC were seeded for 1h in a cell culture flask 
before non-adherent cells were removed. Adherent 
cells were considered as a monocyte/macrophage 
subgroup of PBMC. Thereafter, the cells were washed 
once with PBS (1X) and suspended in buffer containing 
1ml PBS-1% Fetal calf serum (FCS). We stained the 
cells for CD14 marker and then analyzed by flow 
cytometry (FACS Calibour), which was always in the 
range of 90%–95%. The isolated monocytes were used 
freshly or frozen at -130°C for later use. 
 
Phagocytosis Assays 
Phagocytosis was assayed by flow cytometry using 
FITC-dextran.
35
 The removed cells (5×10
4
) were 
suspended in 100µl PBS including 1% bovine serum 
albumin and incubated together with FITC-dextran 
(0.1mg/ml) at 37°C or 4°C for 2hrs as described 
previously.
36
 Incubation was stopped by mixing with 
2ml ice-cold PBS that include 1% human serum and 
0.02% sodium azide. The cells were washed three 
times, with cold PBS and FACS Calibour flow 
cytometer (FACS Calibour, BD bioscience, USA) was 
used for analysis. Specific FITC-dextran uptake of each 
sample was expressed as the total FL1 fluorescence 
intensity at 37°C minus total FL-1 fluorescence 
intensity at 4°C. Relative endocytosis activity was 
calculated using the formula specific FITC-dextran 
uptake of sample/specific FITC-dextran uptake of 
control × 100%. 
 
Trypan Blue Quenching 
In order to eliminate the effects of membrane 
adherent FITC-Dextran, phagocytosis was evaluated  
by comparing the intensity of green fluorescence  
(FITC) before and after trypan blue quenching  
of membrane-bound, labeled dextran. For stopping 
extracellular fluorescence, after exposure to FITC-
Dextran, cells were pelleted by centrifugation (10,000 
xg at 4°C for 5 min) and then resuspended in ice 
-cold 0.2% Trypan blue in 1x PBS (100μl) as 
 described earlier.
37
 Then 10000 cells were analyzed by 
flow cytometry . 
 
TNF- and CXCL-8 Measurements 
Drawing venous blood samples was performed 
between 7:30 and 8:00 AM in the morning before 
having breakfast and for the smoker subjects before the 
first cigarette of the day. Samples were immediately 
centrifuged 10 minutes at a speed of 1500 rpm. Prior to 
analysis the serum was stored at -20°C. The serum 
levels of TNF- and CXCL-8 were analyzed by using 
the mentioned ELISA kits according to manufacture 
Instruction.
38 
The detection threshold level in both kits 
was 31.2 pg/ml. 
 
Statistical Analysis 
Results are presented as means ±standard error of 
the mean (S.E.M.). SPSS v.18.0 software was used to 
analyze the data. Since some of the data sets were not 
normally distributed, group comparisons were 
performed using non parametric tests and  
Kruskal Wallis H test.Spearman’s rank correlation 
coefficients were calculated p<0.05 was considered 
significant. 
 
RESULTS 
 
The important Demographic character of study 
populations was shown below (Table 1). 
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Table 1. Demographic characteristics of smoker and nonsmoker patients with TB and without TB 
Variables Healthy Controls TB-Non-smokers TB-Smoker p value 
Number of subjects 42 38 23  
Age 53.9±4.3 54.2±6.5 53.7±5.2 NS 
Sex(Male %) 30(71%) 17(74%) 11(73%) NS 
Pack/Years 0 0 26.4±16.3  
Marriage status (% single) 15(35.7%) 14(36.8%) 8(34.7%) NS 
Job(manual) 18(42.9%) 18(47.4%) 12(52.2%) <0.05 
Results presented as Mean ±SD where appropriate, NS, not significant 
 
 
Smoker TB Patients Showed Lower Phagocytosis 
Capacity 
A lower percentage of peripheral blood 
monocyte/macrophage cells from smoking TB subjects 
[50.29% (43.4-57.2)] took up FITC-dextran after 2h 
compared with non-smoking TB patients [71.62% 
(69.2-74.1)] and healthy controls [97.45% (95.9-99.1)] 
(Figure 1). Phagocytosis was significantly reduced in 
non-smoking TB subjects compared to healthy controls 
(Figure 1). Inhibition of phagocytosis by cytochalasine 
D (10mg/ml) prevented FITC-dextran uptake (data not 
shown) and cells cultured at 4°C showed significant 
reduced phagocytosis (data not shown).  
We further evaluated in smoker's phagocytosis 
capacity suppression according smoking pack-years, 
there was an inverse correlation between the 
suppression of phagocytosis and pack-years (r=-0.73, 
p<0.001). There was no significant correlation between 
suppression of phagocytosis and any demographic 
factors including age, sex, job, education and marriage 
status. 
 
TB Smokers Have Higher Serum Levels of 
Inflammatory Cytokines 
The serum levels of TNF- and CXCL-8 were 
significantly higher in the smoking TB group than in 
the healthy non-smoking subjects (p<0.01; Figures 2 
and 3). Serum TNF- was also higher in smoking TB 
patients compared to non-smoking TB subjects 
(p<0.05, Figure 2). 
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Figure 1. Suppression of phagocytosis in TB and TB+Smoker patients. 
Uptake of FITC-dextran by peripheral blood monocytes/macrophages was measured by relative fluorescence intensity after 2hrs in 
healthy control subjects and in smoking and non-smoking TB patients. Data are presented as mean±S.E.M. of experiments. *p<0.05, 
**p < 0.01 versus the study's healthy subjects. 
** 
* 
Nonsmoker   Smoker 
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Figure 2. Serum levels of TNF in healthy controls (n=42) and smoking (n=23) and non-smoking (n=38) TB patients. Data are 
presented as mean±S.E.M. *p<0.05, **p<0.01 versus healthy subjects. 
 
 
There was no correlation between TNF- levels and 
pack years or demographic factors between smokers 
TB and smokers. In contrast, there was a positive 
correlation between CXCL-8 increase and pack years 
in the smoking TB group (r=0.58, p<0.05). 
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Figure 3. Serum levels of CXCL8 in healthy controls (n=42) and smoking (n=23) and non-smoking (n=38) TB patients. Data 
are presented as mean ± S.E.M.**p<0.01 versus healthy subjects. 
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DISCUSSION 
 
In the current study blood monocytes/macrophages 
from TB patients showed reduced phagocytic capacity 
which is further reduced in TB patients who smoke. 
Besides, smoking enhanced serum levels of TNF and 
CXCL8 in TB patients above that seen in healthy 
controls. TNF, but not CXCL8, serum levels were 
also elevated in TB patients who smoked compared to 
those who were non-smokers.  
According to the WHO, more than 30% of world's 
population may be infected with Mtb, and in most high-
burden regions, it ranks after cardiovascular disease, as 
the second problem.
39,40
 Each year 8.6 million people 
develop TB disease and 1.3 million die of the disease.
41
 
The association between tobacco smoking and 
tuberculosis has been described recently.
42 
The 
biological mechanisms that affect smoking risk on TB 
infection include decrease in ciliary function, 
alterations in macrophage number and response.
33,34 
Due to suppression effects of tobacco smoking on the 
immune response, studies of this effect on the 
macrophages recently much appreciated.
44 
We have 
shown that TB patients have a reduced phagocytic 
capacity compared to healthy subjects and this is 
further attenuated in TB patients who smoke. Previous 
studies have revealed a lower phagocytosis of smokers 
in comparison with non-smokers.
45
 
One of the most important roles of macrophages in 
the lungs of smokers is clearing the particles entered 
the lungs through tobacco smoking.
46
 In this regard, it 
is of interest to assess the effects of tobacco smoke on 
phagocytic capacity of macrophages. Accordingly, 
macrophages isolated from the lungs of smoke-exposed 
mice were found to have decreased capacity to bind 
and internalize yeasts.
47
 The larger phagolysosomes 
found in lung macrophages of smoker subjects 
compared to non-smokers indicate that regardless of its 
influence on phagocytosis, smoking suppresses the 
breakdown of ingested particles in lysosomes.
48
 These 
observations suggest that a central feature of TB 
pathogenesis involves mycobacterial interference with, 
or evasion of, phagocyte activation pathways which 
normally lead to the killing of ingested organisms. 
This finding is congruent with results of previous 
studies reporting a significant increase in activation of 
TNF- pathway in cigarette smokers.49,50 Production of 
CXCL8 in epithelial cells is also shown to increase 
through exposure to bacterial endotoxin and TNF-.51 
No consensus has been reached on the role of CXCL-8 
in pathogenesis of TB. Several studies have shown that 
multiple growth factors, cytokines and other mediators 
might be able to interact with bacterial pathogens 
influencing the release of inflammatory mediators.
52,53 
It has been proposed that cytokine releases could be 
modulated by smoking.
54 
Our data indicate that CXCL8 
could be associated to TB infection in patients who 
smoke as there was a further increase of serum CXCL-
8 levels and a direct correlation with cigarette smoking 
as defined by pack years in these patients. It can be 
concluded from this observation that a significant 
exposure of cigarette smoke is necessary for activating 
inflammatory processes. Other evidences were 
indicated the serum and BAL fluid's CXCL-8 
concentration increase in active TB patients,
55,56
 even 
in some cases it reached to 8.9 times the normal 
limits.
57 
The increased levels of CXCL-8 in the host 
response against TB infection may be considered as an 
immune response.
58
 However, the precise role of 
CXCL-8 in TB infection remains unclear and merits 
further study specially with considering more control 
group as non TB smoker.  
In conclusion, the results of this study revealed that 
smoking could play role in imbalance of immune 
system in TB patients which may indicate by 
differences in phagocytosis and expression of pro-
inflammatory mediators. Importantly, both 
phagocytosis impairment and CXCL-8 levels elevation 
were modified in TB smokers and it was correlated 
with smoking exposure. This highlights the important 
interactions of cigarette smoking and evasion of 
immune surveillance in TB patients. We speculate that 
serum TNF-, CXCL-8 and phagocytosis may 
considered as useful biomarkers for anticipating 
smoker's immunologic response in TB patients.  
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